The classic website will no longer be available as of June 25, 2024. Please use the modernized ClinicalTrials.gov.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety and Immune Responses After Vaccination With an Investigational RNA-based Vaccine Against Malaria

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT05581641
Recruitment Status : Active, not recruiting
First Posted : October 14, 2022
Last Update Posted : April 3, 2024
Sponsor:
Information provided by (Responsible Party):
BioNTech SE

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Actual Primary Completion Date : February 23, 2024
Estimated Study Completion Date : September 2024